Kerri E. Rieger - Concepedia

Author

Kerri E. Rieger

Also Known As

K Rieger, K. E. Rieger, K. Rieger, K.E. Rieger, Kerri E Rieger, Kerri E. Rieger, Kerri Rieger, M Marinkovich, Rieger, Kerri E.

158

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Stanford University Stanford Medicine Johns Hopkins University University of Pittsburgh University of Virginia

About

Kerri E. Rieger is an author at Stanford University specializing in medicine, pathology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	548
2	Engineering	2	2	44
3	Biomedical Engineering	2	2	44
4	Health Sciences	1	1	155
5	Allergy	1	1	11

Kerri E. Rieger

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients Julia Scarisbrick, Pietro Quaglino, H. Miles Prince, British Journal of Dermatology	2018	216
Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa Zurab Siprashvili, Ngon T. Nguyen, Emily S. Gorell, JAMA	2016	209
Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells Kerri E. Rieger Nucleic Acids Research Ultraviolet LightUltraviolet RadiationDna DamageGeneticsRadiation Effect	2004	155
Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage Kerri E. Rieger, Wan‐Jen Hong, Virginia Goss Tusher, Proceedings of the National Academy of Sciences	2004	122
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study Anne Lynn S. Chang, Duy Tran, John G. D. Cannon, Journal of the American Academy of Dermatology	2018	114
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa Shaundra Eichstadt, M. Barriga, Anusha Ponakala, JCI Insight	2019	106
<scp>PRAME</scp> expression in melanocytic proliferations with intermediate histopathologic or spitzoid features Shyam S. Raghavan, Jennifer Y. Wang, Shirley Kwok, Journal of Cutaneous Pathology	2020	106
Identification of H-ras Mutations in Urine Sediments Complements Cytology in the Detection of Bladder Tumors J. Mark FitzGerald, Nirasha Ramchurren, Kerri E. Rieger, JNCI Journal of the National Cancer Institute	1995	95
Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy Azael Freites‐Martínez, Bernice Y. Kwong, Kerri E. Rieger, JAMA Dermatology	2017	84
Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study* Pietro Quaglino, H. Miles Prince, Richard Cowan, British Journal of Dermatology	2020	81

Page 1